Quality Assurance (QA) in Radiation Oncology

Quality Assurance (QA) in radiation oncology consists of structured procedures designed to ensure that a radiotherapy facility delivers the prescribed radiation dose to the correct target volume safely, accurately, and consistently. Modern radiotherapy involves highly complex technologies—such as Volumetric Modulated Arc Therapy (VMAT), stereotactic radiosurgery (SRS), and image-guided systems—making a robust QA program essential to prevent catastrophic treatment errors.

This article reviews the guidelines of the American Association of Physicists in Medicine (AAPM) Task Group 142 (TG-142) report, detailing mechanical, dosimetric, safety, and imaging QA protocols.

1. Philosophy of QA: Tolerances and Action Levels

A QA program is built around two concepts: * Tolerance Limit: The maximum acceptable deviation of a parameter from its baseline value under normal operating conditions. If a parameter exceeds tolerance but is below the action limit, the machine can continue to be used, but the physicist must schedule maintenance. * Action Level: The threshold at which the machine must be immediately taken out of clinical service. Patient treatments are suspended until the issue is diagnosed and corrected by a service engineer or medical physicist.

Tolerances are customized based on the treatment techniques offered. For example, a machine performing stereotactic radiosurgery (SRS) has a mechanical gantry isocenter tolerance of \pm 1 mm, whereas a machine performing conventional 3D-CRT has a tolerance of \pm 2 mm.

2. Categorization of QA Procedures

TG-142 divides quality assurance into daily, monthly, and annual tests. This frequency corresponds to the likelihood of parameter drift and the severity of the consequences if a parameter fails.

Daily QA Daily tests are performed by radiation therapists before the first patient treatment of the day. They focus on basic safety interlocks and major dosimetric/mechanical parameters: * **Dosimetry**: Output constancy for both photons and electrons (tolerance $\pm 3\%$). * **Mechanical**: Positioning of room lasers and the Optical Distance Indicator (ODI) at isocenter (tolerance $\pm 2\text{ mm}$ for non-SRS, $\pm 1\text{ mm}$ for SRS). * **Safety**: Door interlock, audio/visual intercom system, and beam-on indicator lights (must be fully functional; tolerance: pass/fail).

Monthly QA Monthly tests are performed by a medical physicist and involve more detailed assessments of beam parameters and mechanical readouts: * **Dosimetry**: Backup ion chamber constancy, beam profile flatness and symmetry (tolerance $\pm 1\%$ deviation from baseline), and output constancy (tolerance $\pm 2\%$). * **Mechanical**: Collimator, gantry, and couch rotation isocenter checks (tolerance $\pm 2\text{ mm}$). Jaw position readouts and light-vs-radiation field congruence (tolerance $\pm 2\text{ mm}$). * **Safety**: Laser interlocks and emergency stop buttons.

Annual QA Annual QA is the most comprehensive testing phase, performed by the medical physics team over several days. It establishes new baselines and verifies the machine's absolute calibration: * **Absolute Dosimetry**: Absolute dose calibration under reference conditions (TG-51 protocol) to ensure $1\text{ cGy/MU}$ output (tolerance $\pm 1\%$). * **Beam Energy Verification**: Measurement of Percent Depth Dose (PDD) curves in water to verify that the energy matches commissioning data (tolerance $\pm 1\%$ change in $%\text{dd}(10)_x$). * **Isocenter Precision (Winston-Lutz Test)**: Verifies the coincidence of the gantry, collimator, and couch rotation axes. A small ball-bearing is imaged at various angles, and the offset between the ball and the radiation field center is calculated. For SRS systems, the combined mechanical isocenter radius must be $< 1.0\text{ mm}$.

3. Imaging QA

Modern linear accelerators feature integrated imaging systems for Image-Guided Radiation Therapy (IGRT). These include Kilovoltage (kV) and Megavoltage (MV) planar imagers, as well as Cone-Beam CT (CBCT) systems. Imaging QA (detailed in TG-142 and TG-179) ensures that these systems provide accurate targeting: * Spatial Resolution: Verifies the imager's ability to resolve fine structures (using line-pair phantoms). * Contrast-to-Noise Ratio (CNR): Evaluates the system's ability to differentiate soft tissues. * Imaging-to-Treatment Coordinate Coincidence: Ensures that the target positioned at the imaging center aligns perfectly with the radiation isocenter. This is checked using the "cube" or "pips" phantom (tolerance \pm 1 mm).

4. Patient-Specific QA

In addition to machine QA, patient-specific QA must be performed for all modulated treatments (IMRT and VMAT). Because these plans deliver complex, dynamic fluence patterns, the dose distribution must be verified before the first treatment: 1. Measurement-Based Verification: The patient's plan is calculated on a QA phantom containing a 2D diode array (e.g., MapCHECK) or a 3D cylindrical array (e.g., ArcCHECK). 2. Gamma Index Analysis: The measured dose is compared to the treatment planning system (TPS) calculated dose. The plan passes if a target percentage of points (typically > 95\%) satisfies the Gamma criteria, which combines dose difference and distance-to-agreement (commonly 3\% / 2 mm or 2\% / 2 mm).

5. Culture of Safety and Incident Reporting

A technical QA program is only as effective as the safety culture of the department. Medical physicists are responsible for establishing: * Peer Review: Regular chart rounds where physicians, physicists, and dosimetrists review treatment plans before delivery. * Standard Operating Procedures (SOPs): Clear workflows for plan transfer, patient identification, and override of machine interlocks. * Incident Learning Systems: Utilizing frameworks like RO-ILS (Radiation Oncology Incident Learning System) to document near-misses, analyze root causes (using Failure Mode and Effects Analysis - FMEA), and implement corrective actions.

Conclusion

Quality Assurance is not merely a collection of technical measurements; it is a clinical shield that protects patients from treatment errors. By implementing a systematic testing hierarchy—ranging from daily checks to advanced annual calibrations—and maintaining a rigorous patient-specific verification workflow, medical physicists guarantee that radiation oncology remains both highly effective and exceptionally safe.